Titlebook: Klimabericht für die Metropolregion Hamburg; Hans von Storch,Martin Claussen Book 2011 Springer-Verlag Berlin Heidelberg 2011 Anpassungsst

使入伍

書目名稱Klimabericht für die Metropolregion Hamburg影響因子(影響力)




書目名稱Klimabericht für die Metropolregion Hamburg影響因子(影響力)學(xué)科排名




書目名稱Klimabericht für die Metropolregion Hamburg網(wǎng)絡(luò)公開度




書目名稱Klimabericht für die Metropolregion Hamburg網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Klimabericht für die Metropolregion Hamburg被引頻次




書目名稱Klimabericht für die Metropolregion Hamburg被引頻次學(xué)科排名




書目名稱Klimabericht für die Metropolregion Hamburg年度引用




書目名稱Klimabericht für die Metropolregion Hamburg年度引用學(xué)科排名




書目名稱Klimabericht für die Metropolregion Hamburg讀者反饋




書目名稱Klimabericht für die Metropolregion Hamburg讀者反饋學(xué)科排名

磨坊

Martin Claussen,Hans von Storchatched sibling donors in the 1980s, matched unrelated donors and cord blood sources in the 1990s, and haploidentical donors in the 2000s. Many studies have solidified hematopoietic progenitors from matched sibling marrow, cord blood, or mobilized peripheral blood as the best source—with the lowest g

懲罰

atched sibling donors in the 1980s, matched unrelated donors and cord blood sources in the 1990s, and haploidentical donors in the 2000s. Many studies have solidified hematopoietic progenitors from matched sibling marrow, cord blood, or mobilized peripheral blood as the best source—with the lowest g

可轉(zhuǎn)變

Gudrun Rosenhagen,Michael Schatzmann,Anne Schr?nst promising treatment modality. However, expression of therapeutic genes and proper localization of the expressed proteins require a complex interactive environment within the target cells or tissues for ultimately being clinically applicable. Our knowledge of molecular pathways, cell biology, and

Flatter

Achim Daschkeitulated by certain chemical reactions that modulate parts of the genome at specific intervals involving the remodeling of chromatin. Understanding how chromatin remodeling can selectively activate or inactivate genes and subsequently influence pathogenesis and the outcome of many diseases becomes cri

大范圍流行

大雨

Norbert Winkelultiple hematological malignancies with potential for long term cure. However, multiple hurdles remain to be overcome. Some issues are inherent to CAR-T cells, such as suboptimal expansion, rapid exhaustion, or rejection. Other problems are related to the immunosuppressive tumor microenvironment, wh

制定法律

thalamus

Kai JensenA) approval was in 2017 for CD19-directed CAR-T cell therapy using tisagenlecleucel (tisa-cel) for the treatment of pediatric patients (up to age 25) with relapsed or refractory (R/R) B-acute lymphoblastic leukemia (B-ALL). That same year, CD19 CAR-T cell therapy with axicabtagene ciloleucel (axi-ce

nepotism